Press Releases
Relmada Therapeutics to Present at LD Micro "Main Event" Investor Conference
Relmada Therapeutics to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention
Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms
Relmada Therapeutics to Present at the 15th Annual BIO Investor Forum
Relmada Therapeutics' Chief Scientific Officer Dr. Richard Mangano to Speak about d-Methadone as a Potential Rapid Acting Antidepressant at Neuro Advance Boston
Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Relmada Therapeutics to Present at the 2016 Aegis Growth Conference
Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern
Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team
Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
